In 2023, Germany led in hospital discharges for leiomyoma of the uterus with 50.45 thousand cases, though it saw a 2.04% decline from the previous year. Poland was unique with a slight increase of 0.14%. Notable declines were observed in Spain, Netherlands, and Hungary, with rates of -0.7%, -3.02%, and -3.15%, respectively. Israel marked a significant increase of 4.09% year-on-year. The rest of the countries showed varied trends with minor changes.
Future trends to monitor include potential advancements in outpatient treatments, which could reduce discharge rates, and demographic changes that might influence demand for uterine leiomyoma-related healthcare services.
Top countries in Hospital Discharges for Leiomyoma of Uterus by Country
| # | 10 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 50,450 | 2023 | -0.26% | -2.04% | View data |
| 2 | 2 Poland | 25,380 | 2023 | +5.59% | +0.14% | View data |
| 3 | 3 Spain | 18,810 | 2023 | +2.15% | -0.7% | View data |
| 4 | 4 United Kingdom | 17,270 | 2023 | -1.03% | -1.02% | View data |
| 5 | 5 Chile | 12,610 | 2023 | +7.08% | -0.59% | View data |
| 6 | 6 Switzerland | 5,790 | 2023 | +2.93% | +0.43% | View data |
| 7 | 7 Austria | 4,620 | 2023 | +3.03% | +0.2% | View data |
| 8 | 8 Belgium | 4,490 | 2023 | +0.38% | -1.68% | View data |
| 9 | 9 Netherlands | 3,440 | 2023 | +0.44% | -3.02% | View data |
| 10 | 10 Hungary | 3,400 | 2023 | +0.5% | -3.15% | View data |
